Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126001731 | 12600173 | 1 | I | 2015 | 20160627 | 20160727 | 20160727 | EXP | PHHY2016FR091391 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160727 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126001731 | 12600173 | 1 | PS | EXELON PATCH | RIVASTIGMINE | 1 | Transdermal | 9.5 UG, QD | N | 22083 | 9.5 | UG | TRANS-THERAPEUTIC-SYSTEM | QD | |||||
| 126001731 | 12600173 | 2 | C | AROMASINE | EXEMESTANE | 1 | Unknown | UNK | N | 0 | |||||||||
| 126001731 | 12600173 | 3 | C | DIFFU K | POTASSIUM CHLORIDE | 1 | Unknown | UNK | 0 | ||||||||||
| 126001731 | 12600173 | 4 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 126001731 | 12600173 | 5 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Unknown | 25 MG, UNK | 0 | 25 | MG | ||||||||
| 126001731 | 12600173 | 6 | C | METEOSPASMYL | ALVERINE CITRATEDIMETHICONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126001731 | 12600173 | 7 | C | FLECAINE LP | FLECAINIDE | 1 | Unknown | 100 MG, UNK | U | 0 | 100 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126001731 | 12600173 | 1 | Dementia Alzheimer's type |
| 126001731 | 12600173 | 2 | Breast neoplasm |
| 126001731 | 12600173 | 3 | Pulmonary oedema |
| 126001731 | 12600173 | 4 | Pulmonary oedema |
| 126001731 | 12600173 | 5 | Hypothyroidism |
| 126001731 | 12600173 | 6 | Product used for unknown indication |
| 126001731 | 12600173 | 7 | Heart rate irregular |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126001731 | 12600173 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126001731 | 12600173 | Decreased appetite | |
| 126001731 | 12600173 | Dementia Alzheimer's type | |
| 126001731 | 12600173 | Fatigue | |
| 126001731 | 12600173 | Gamma-glutamyltransferase increased | |
| 126001731 | 12600173 | Insomnia | |
| 126001731 | 12600173 | Metastases to liver | |
| 126001731 | 12600173 | Off label use | |
| 126001731 | 12600173 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126001731 | 12600173 | 1 | 201503 | 0 | ||
| 126001731 | 12600173 | 2 | 201506 | 0 |